Annual CAPEX
N/A
December 31, 2023
Summary
- XENE annual capital expenditures is not available.
Performance
XENE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- XENE quarterly capital expenditures is not available.
Performance
XENE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- XENE TTM capital expenditures is not available.
Performance
XENE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
XENE CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
XENE CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Xenon Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $2.89 M(+41.2%) | - | - |
| Sep 2022 | - | $386.00 K(-29.0%) | $1.66 M(+10.9%) |
| Jun 2022 | - | $544.00 K(+156.6%) | $1.49 M(-19.6%) |
| Mar 2022 | - | $212.00 K(-58.8%) | $1.86 M(-9.4%) |
| Dec 2021 | $2.05 M(-22.3%) | $514.00 K(+130.5%) | $2.05 M(-13.3%) |
| Sep 2021 | - | $223.00 K(-75.5%) | $2.36 M(-19.4%) |
| Jun 2021 | - | $909.00 K(+125.0%) | $2.93 M(+22.6%) |
| Mar 2021 | - | $404.00 K(-51.2%) | $2.39 M(-9.2%) |
| Dec 2020 | $2.64 M(+112.7%) | $828.00 K(+4.4%) | $2.64 M(+9.7%) |
| Sep 2020 | - | $793.00 K(+114.9%) | $2.40 M(+45.2%) |
| Jun 2020 | - | $369.00 K(-43.0%) | $1.66 M(+6.7%) |
| Mar 2020 | - | $647.00 K(+8.7%) | $1.55 M(+25.2%) |
| Dec 2019 | $1.24 M(+144.6%) | $595.00 K(+1222.2%) | $1.24 M(+52.1%) |
| Sep 2019 | - | $45.00 K(-83.0%) | $815.00 K(+3.3%) |
| Jun 2019 | - | $265.00 K(-20.9%) | $789.00 K(+19.4%) |
| Mar 2019 | - | $335.00 K(+97.1%) | $661.00 K(+30.4%) |
| Dec 2018 | $507.00 K | $170.00 K(+794.7%) | $507.00 K(+26.8%) |
| Sep 2018 | - | $19.00 K(-86.1%) | $400.00 K(+1.3%) |
| Jun 2018 | - | $137.00 K(-24.3%) | $395.00 K(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $181.00 K(+187.3%) | $359.00 K(+14.0%) |
| Dec 2017 | $315.00 K(+12.9%) | $63.00 K(+350.0%) | $315.00 K(+12.5%) |
| Sep 2017 | - | $14.00 K(-86.1%) | $280.00 K(-10.3%) |
| Jun 2017 | - | $101.00 K(-26.3%) | $312.00 K(-6.3%) |
| Mar 2017 | - | $137.00 K(+389.3%) | $333.00 K(+19.4%) |
| Dec 2016 | $279.00 K(-49.4%) | $28.00 K(-39.1%) | $279.00 K(-29.2%) |
| Sep 2016 | - | $46.00 K(-62.3%) | $394.00 K(-30.4%) |
| Jun 2016 | - | $122.00 K(+47.0%) | $566.00 K(+2.9%) |
| Mar 2016 | - | $83.00 K(-42.0%) | $550.00 K(-0.2%) |
| Dec 2015 | $551.00 K(-64.0%) | $143.00 K(-34.4%) | $551.00 K(-53.5%) |
| Sep 2015 | - | $218.00 K(+105.7%) | $1.18 M(-3.1%) |
| Jun 2015 | - | $106.00 K(+26.2%) | $1.22 M(+7.9%) |
| Mar 2015 | - | $84.00 K(-89.2%) | $1.13 M(-25.9%) |
| Dec 2014 | $1.53 M(+880.1%) | $776.00 K(+203.1%) | $1.53 M(+103.1%) |
| Sep 2014 | - | $256.00 K(+1405.9%) | $753.00 K(+51.5%) |
| Jun 2014 | - | $17.00 K(-96.5%) | $497.00 K(+3.5%) |
| Mar 2014 | - | $480.00 K | $480.00 K |
| Dec 2013 | $156.00 K(-70.3%) | - | - |
| Dec 2012 | $526.00 K(+81.4%) | - | - |
| Dec 2011 | $290.00 K | - | - |
FAQ
- What is the all time high annual CAPEX for Xenon Pharmaceuticals?
- What is the all time high quarterly CAPEX for Xenon Pharmaceuticals?
- What is the all time high TTM CAPEX for Xenon Pharmaceuticals?
What is the all time high annual CAPEX for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual capital expenditures is $2.89 M
What is the all time high quarterly CAPEX for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly capital expenditures is $909.00 K
What is the all time high TTM CAPEX for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM capital expenditures is $2.93 M